| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NUTX | Class A Common Stock | Sale | -$277K | -125K | -0.3% | $2.21* | 42M | Dec 12, 2022 | Direct | F1, F2, F3 |
| transaction | NUTX | Class A Common Stock | Sale | -$90.6K | -43.9K | -0.1% | $2.06* | 42M | Dec 13, 2022 | Direct | F1, F3, F4 |
| Id | Content |
|---|---|
| F1 | These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by Premier Macy Management Holdings, LLC ("Premier"). |
| F2 | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.04 to $2.445, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1. |
| F3 | Premier is the direct beneficial owner of the securities reported herein. Matthew Stephen Young is the managing member of Premier and a director of Nutex Health, Inc. Mr. Young disclaims beneficial ownership of any securities that exceed his pecuniary interest in Premier. |
| F4 | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.04 to $2.12, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2. |